Alba M. Redondo
Salamanca, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO.
Journal: British journal of haematology
Published: February 20, 2023
Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity.
Journal: British journal of haematology
Published: February 19, 2019
Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up.
Journal: Stem cell research & therapy
Published: November 14, 2018
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group.
Journal: British journal of haematology
Published: July 01, 2018
Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model.
Journal: European journal of haematology
Published: June 14, 2018
Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease).
Journal: Stem cell research & therapy
Published: March 29, 2018
Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis.
Journal: PloS one
Published: March 09, 2017
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.
Journal: British journal of haematology
Published: September 16, 2015
MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry.
Journal: Cell communication and signaling : CCS
Published: June 24, 2015
Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?
Journal: Annals of hematology
Published: June 01, 2014
Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: April 09, 2014
Last Updated: 09/26/2026